Axsome Therapeutics, Inc.
AXSM
$224.03
$7.563.49%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -64.54M | -28.56M | -47.23M | -47.97M | -59.41M |
| Total Depreciation and Amortization | 2.37M | 2.27M | 2.41M | 2.25M | 2.13M |
| Total Amortization of Deferred Charges | 159.00K | 161.00K | 158.00K | 317.00K | 667.00K |
| Total Other Non-Cash Items | 24.26M | 14.83M | 36.92M | 27.32M | 23.39M |
| Change in Net Operating Assets | 17.05M | -7.36M | 8.78M | -14.33M | -10.15M |
| Cash from Operations | -20.70M | -18.65M | 1.05M | -32.42M | -43.38M |
| Capital Expenditure | -121.00K | -71.00K | -58.00K | -13.00K | -338.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -121.00K | -71.00K | -58.00K | -13.00K | -338.00K |
| Total Debt Issued | 70.00M | 70.00M | 70.00M | 190.00M | -- |
| Total Debt Repaid | -70.67M | -70.54M | -70.66M | -192.51M | -401.00K |
| Issuance of Common Stock | 16.32M | 21.01M | 25.47M | 44.29M | 36.69M |
| Repurchase of Common Stock | -9.30M | -1.04M | -842.00K | -888.00K | -4.34M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.36M | -3.04M | -2.70M | -6.36M | -2.68M |
| Cash from Financing | 2.99M | 16.39M | 21.27M | 34.54M | 29.27M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -17.83M | -2.34M | 22.26M | 2.11M | -14.44M |